Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Jun 12, 2022 12:09pm
211 Views
Post# 34750075

RE:RE:RE:RE:RE:10% in 3 days

RE:RE:RE:RE:RE:10% in 3 daysd hiring at TH has hardly been exceptional. Even on the scientific side, they have not hired an inordiate number of people and the rest is just normal, probably most of it reflecting turnover. Also, the Chief of Staff position is no longer posted and by scrolling through the staff on LinkedIn a few weeks ago, I did not find anyone in that role. So, it looks like that idea was dropped. Perhaps the board told Paul they did not think that position was necessary and that there was a limit to what the company could afford for the CEO's office. The staff has grown in the two years since Paul took over and compensation costs have certainly increased even more as he upgraded the staff at the same time, but the overall headcount does not seem to have risen drammatically in the last 6-9 months. 

The hiring of the IR and Communications directors on the last day of the second quarter (pushing those expenses into the fiscal third qquarter) tells you they are still keeping an eye on the bottom line as well as they are still confident about their future (likely wouldn't hire them if TH-1902 were a complete dud). 

As for a second ONO, having done the first, they are clearly at risk of doing a second one, especially given the current market conditions. They will not shake off the bad reputation for the first one until they avoid a second one. I am not sure the board, CEO and CFO would survive a second ONO, however. And they likely know that. The chairwoman only got 77% of the vote at May's AGM and that was with the larger shareholders like myself and others I know voting for her. 

Biobob wrote: This hiring gone unexplained like this gives the impression that their CEO think the size of a company is fonction of the headcount.  The build it and they will come mentality.  I personnally fear we will pay for this nonsense before long in the form of an OO no.2.  They will give more and new reasons to justify this fact when it occurs maybe with the help of this latest addition to their top heavy management staff. 


<< Previous
Bullboard Posts
Next >>